2013
DOI: 10.7314/apjcp.2013.14.10.6109
|View full text |Cite
|
Sign up to set email alerts
|

Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
35
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(37 citation statements)
references
References 29 publications
1
35
0
Order By: Relevance
“…Lung cancers rank the top of cancer-related death with increasing morbidity around the world (Aydiner et al, 2013;Cai et al, 2013;Kaya et al, 2013;Mutlu et al, 2013;Natukula et al, 2013;Oven et al, 2013;Unal et al, 2013;Wang et al, 2013). At present, the chemotherapeutic protocols for NSCLC mainly apply platinums as basic drugs combining with the third generation chemotherapeutic drugs such as paclitaxel, gemcitabine and vinorelbine, etc..…”
Section: Discussionmentioning
confidence: 99%
“…Lung cancers rank the top of cancer-related death with increasing morbidity around the world (Aydiner et al, 2013;Cai et al, 2013;Kaya et al, 2013;Mutlu et al, 2013;Natukula et al, 2013;Oven et al, 2013;Unal et al, 2013;Wang et al, 2013). At present, the chemotherapeutic protocols for NSCLC mainly apply platinums as basic drugs combining with the third generation chemotherapeutic drugs such as paclitaxel, gemcitabine and vinorelbine, etc..…”
Section: Discussionmentioning
confidence: 99%
“…NSCLC patients take up 80%~85% of total cases in lung cancer (Mutlu et al, 2013;Oven et al, 2013;Aydiner et al, 2013;Cai et al, 2013;Kaya et al, 2013;Natukula et al, 2013;Unal et al, 2013;Wang et al, 2013) and patients with locally advanced NSCLC who can't receive surgery were mainly treated with radiotherapy, the effect of which was mainly marked with dose-dependence. Although highdose radiotherapy can improve the remission rate and local control rate, at the same time, it can bring about severe side effects, such as severe radiation esophagitis and radiation pneumonitis (Feng et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Lung cancer is a common malignant tumor in China, and NSCLC patients take up 80%~85% of total cases in lung cancer (Aydiner et al, 2013;Cai et al, 2013;Kaya et al, 2013;Mutlu et al, 2013;Natukula et al, 2013;Oven et al, 2013;Unal et al, 2013;Wang et al, 2013). How to effectively treat patients with lung cancer is a focus in clinical settings (Yan et al, 2009).…”
Section: Introductionmentioning
confidence: 99%